Clinical trial · Observational
Prostate Cancer Care Disparity Analysis Project (ProGAP)
Evaluating the Worldwide Landscape of Prostate Cancer Management
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income. The primary question it addresses is: Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide? To achieve this, we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications. Participants will complete a 17-question online survey.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate CA | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Intervention: Observational Cohort | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Healthcare professionals for prostate cancer
- description
- Healthcare professionals actively engaged in prostate cancer treatment, including urologists, uro-oncologists, medical oncologists, and radiation oncologists
- interventionNames
- Other: No Intervention: Observational Cohort
Primary outcomes (1)
- measure
- Characterization of global disparities in prostate cancer diagnosis, treatment, and management practices
- timeFrame
- One month
- description
- Comparative analyses will be conducted using survey data to reveal disparities between different regions and healthcare settings. The findings will be presented as percentages of respondents, with territorial and institutional differences thoroughly evaluated. Participants will be categorized into three groups based on the World Bank\'s income classification: low and lower-middle, upper-middle, and high-income countries. Descriptive statistics will be employed to compare demographic characteristics and clinical practices. For categorical data analysis, the Pearson Chi-Square or Fisher\'s Exact test will be utilized, while ANOVA tests will be applied to independent variables. A p-value of less than 0.05 will be considered statistically significant.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Urologists, Uro-oncologists, Medical oncologists, Radiation oncologists Exclusion Criteria: Non-clinical healthcare professionals Healthcare professionals not directly involved in the care of prostate cancer patients, Healthcare professionals with missing or incorrect email addresses
References
Publications (0)
Data not yet available